Skip to main content

Table 3 IL28B genotype expression in non-diabetic and diabetic groups according to grades of fibrosis

From: Impact of IL-28B gene polymorphism on chronic hepatitis-C patients progression with diabetes and non-diabetes

Variable

CC

CT

TT

χ2

P

G1 a and b non-diabetic

(n = 80)

Fibrosis

(n = 40)

18 (45.0%)

15

(37.5%)

7

(17.5%)

2.65

0.27*

Cirrhosis

(n = 40)

11 (27.5%)

20

(50%)

9

(22.5%)

OR(95%CI)

1

2.18

(0.71–6.78)

2.1

(0.52–8.79)

GII a and b diabetic

(n = 80)

Fibrosis

(n = 40)

6 (15.0%)

26

(65.0%)

8

(20.0%)

2.26

0.32*

Cirrhosis

(n = 40)

5 (12.5%)

21

(52.5%)

14

(35.0%)

OR(95%CI)

1

0.97

(0.22–4.36)

2.1

(0.39–11.87)

  1. X2 = Chi-square test *: nonsignificant = p > 0.05